Introduction of pharmacogenetic screening to HIV clinical practice: Potential benefits and challenges
*No subscription required
It has long been recognised that individuals vary in their susceptibility to diseases and in their response to drugs, but it is only in the last 50 years that progress has been made in elucidating the genetic basis of this phenomenon. The term ‘pharmacogenetics’ was coined by Friedrich Vogel in 1959 to denote the effects of polymorphisms within a particular human gene on the disposition and action of drugs...
|Publication Type:||Journal Article|
|Murdoch Affiliation:||Centre for Clinical Immunology and Biomedical Statistics|
|Copyright:||2007 Touch Briefings|
|Item Control Page|
Downloads per month over past year